UPDATE: Jefferies Upgrades Sabra Health Care REIT on Attractive Entry Point

By: Benzinga
In a report published Wednesday, Jefferies analyst Omotayo Okusanya upgraded the rating on Sabra Health Care REIT (NASDAQ: SBRA ) from Hold to Buy, but lowered the price target from $27.00 to $26.00. In the report, Jefferies noted, “We had previously downgraded SBRA stock from Buy to Hold back in
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.